The SNAP trial: a randomised placebo-controlled trial of nicotine replacement therapy in pregnancy – clinical effectiveness and safety until 2 years after delivery, with economic evaluation
Author(s) -
Sue Cooper,
Sarah Lewis,
Jim Thornton,
Neil Marlow,
Kim Watts,
John Britton,
Matthew J. Grainge,
Jaspal Taggar,
Holly Essex,
Steve Parrott,
Anne Dickinson,
Rachel Whitemore,
Tim Coleman
Publication year - 2014
Publication title -
health technology assessment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.426
H-Index - 126
eISSN - 2046-4924
pISSN - 1366-5278
DOI - 10.3310/hta18540
Subject(s) - medicine , pregnancy , nicotine replacement therapy , smoking cessation , randomized controlled trial , placebo , childbirth , obstetrics , abstinence , physical therapy , pediatrics , surgery , psychiatry , alternative medicine , genetics , pathology , biology
Smoking during pregnancy causes many adverse pregnancy and birth outcomes. Nicotine replacement therapy (NRT) is effective for cessation outside pregnancy but efficacy and safety in pregnancy are unknown. We hypothesised that NRT would increase smoking cessation in pregnancy without adversely affecting infants.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom